Beijing Centergate: NMPA Approves Clinical Trial of BDB Tablets for Hypertension
Beijing Centergate Technologies Holding Co Ltd (SZSE:000931) announced that the NMPA has approved the clinical trial of its BDB Tablets for hypertension.
Beijing Centergate Technologies Holding Co Ltd (SZSE:000931) announced that the NMPA has approved the clinical trial of its BDB Tablets for hypertension.